Robert Tepper Net Worth & Insider Trades
Robert Tepper Jounce Therapeutics, Inc
What is Robert Tepper's Net Worth?
The current estimated net worth of Jounce Therapeutics, Inc's Robert Tepper is estimated to be about $1.4B . Robert Tepper owns about 1,432,638 units of Jounce Therapeutics, Inc common stock. In the last 4 years at Jounce Therapeutics, Inc, Robert Tepper has sold an estimated value of $37.59M worth.
What is Robert Tepper's Past Insider Trading?
Robert Tepper's largest sale order was 1,450,000 units , worth over $17.04M on March 3, 2021. In total, Robert Tepper has made about 13 transactions over 4 years of their time at Jounce Therapeutics, Inc. Robert Tepper usually trades in June and November, with the busiest year in 2021. The most recent transaction was a sale order of 1,900,000 units , worth over $15.92M on November 16, 2021.
Third Rock Ventures III LP, Third Rock Ventures GP III LP, TRV GP III LLC, KEVIN STARR, ROBERT TEPPER, MARK LEVIN
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Robert Tepper's' Mailing Address?
- Mailing address is 29 Newbury Street 3rd Floor Boston MA 02116 MA
Jounce Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard Murray, Ph.D., | 2020 | $565,100 | $310,810 | $491,316 | $627,312 | $8,946 | $2,003,484 |
| Richard Murray, Ph.D., | 2019 | $540,800 | $295,500 | $275,044 | $348,665 | $8,796 | $1,468,805 |
| Hugh M. Cole | 2020 | $420,000 | $212,520 | $196,500 | $250,908 | $8,808 | $1,088,736 |
| Hugh M. Cole | 2019 | $401,700 | $153,700 | $97,900 | $124,115 | $5,709 | $783,124 |
| Kim C. Drapkin | 2020 | $398,400 | $175,300 | $174,885 | $223,308 | $8,688 | $980,581 |
| Kim C. Drapkin | 2019 | $381,200 | $145,800 | $97,900 | $124,115 | $8,796 | $757,811 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm
What are Jounce Therapeutics, Inc's Past Insider Trades?
Jounce Therapeutics, Inc's most recent insider trade came on January 11, 2022 by Elizabeth Trehu who sold 8,383 units worth $57.7K . In the last 5 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $42.43M and bought an estimated value of $10.7M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Elizabeth Trehu, Chief Medical Officer, Kimberlee C Drapkin, CFO and Treasurer, and Ca Richard Murray, CEO and President .
Jounce Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||